Kronox Lab Sciences Ltd

AI
Kronox Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Kronox Lab Sciences Ltd

₹ 200 -4.49%
19 Oct - close price
kronoxlabsciences.com BSE: 544187 NSE: KRONOX
About

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]

Key Points

Business Overview:[1][2]
KLSL is in High Purity Speciality Fine Chemicals Business with portfolio of about 185 products including Excipients and ingredients, High Purity Reagents, Pharmaceutical, nutraceutical and Food Chemical.

Website BSE NSE - BE
  • Market Cap ₹ 738 Cr.
  • Current Price ₹ 200
  • High / Low ₹ 228 / 96.0
  • Stock P/E 25.8
  • Book Value ₹ 31.3
  • Dividend Yield 0.25 %
  • ROCE 36.0 %
  • ROE 26.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 23.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 31.4%
  • Company's working capital requirements have reduced from 93.3 days to 71.2 days

Cons

  • The company has delivered a poor sales growth of 10.1% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
25.95 21.02 20.71 22.18 25.19 24.86 24.01 26.13 24.29 25.53 25.27 26.13 28.39
17.43 15.16 14.63 14.33 16.98 16.06 15.65 18.38 16.32 16.88 17.24 16.61 19.40
Operating Profit 8.52 5.86 6.08 7.85 8.21 8.80 8.36 7.75 7.97 8.65 8.03 9.52 8.99
OPM % 32.83% 27.88% 29.36% 35.39% 32.59% 35.40% 34.82% 29.66% 32.81% 33.88% 31.78% 36.43% 31.67%
0.24 0.49 0.02 0.83 0.43 0.36 0.82 0.91 0.87 1.04 1.13 2.15 1.30
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.04 0.04 0.03
Depreciation 0.32 0.38 0.30 0.29 0.33 0.34 0.36 0.35 0.40 0.47 0.52 0.66 0.45
Profit before tax 8.44 5.97 5.80 8.39 8.31 8.82 8.82 8.31 8.44 9.18 8.60 10.97 9.81
Tax % 24.53% 27.14% 18.28% 29.92% 25.99% 26.64% 26.08% 24.07% 25.71% 27.23% 23.37% 26.98% 25.59%
6.38 4.35 4.74 5.88 6.15 6.47 6.53 6.32 6.28 6.68 6.59 8.00 7.30
EPS in Rs 1.72 1.17 1.28 1.58 1.66 1.74 1.76 1.70 1.69 1.80 1.78 2.16 1.97
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
50 62 82 96 90 100 101 105
39 48 63 74 62 67 67 70
Operating Profit 12 15 20 22 28 33 34 35
OPM % 23% 24% 24% 23% 32% 33% 34% 33%
1 1 1 2 2 3 5 6
Interest 0 0 0 0 0 0 0 0
Depreciation 1 2 2 2 1 1 2 2
Profit before tax 12 13 18 22 29 34 37 39
Tax % 27% 26% 26% 26% 25% 26% 26%
9 10 14 16 21 25 28 29
EPS in Rs 2.12 2.49 3.49 4.42 5.75 6.86 7.45 7.71
Dividend Payout % 0% 0% 0% 0% 9% 7% 7%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 2%
TTM: 6%
Compounded Profit Growth
10 Years: %
5 Years: 23%
3 Years: 19%
TTM: 12%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 32%
Return on Equity
10 Years: %
5 Years: 33%
3 Years: 31%
Last Year: 27%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.25 0.24 0.24 37 37 37 37
Reserves 23 27 40 8 29 53 79
0 4 3 0 0 0 2
11 7 13 9 8 9 10
Total Liabilities 34 38 57 54 74 99 128
6 9 11 16 26 28 29
CWIP 0 0 0 0 0 1 1
Investments 0 0 0 0 0 0 0
29 28 45 38 47 70 98
Total Assets 34 38 57 54 74 99 128

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
4 11 9 20 17 31 24
-4 -3 -8 -7 -17 -28 -24
-0 -7 -1 -13 0 -2 -0
Net Cash Flow 0 1 1 -0 0 0 -0
Free Cash Flow 3 10 5 11 5 28 21
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 65% 100% 70% 117% 87% 120% 98%

Ratios

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 110 90 114 71 72 72 76
Inventory Days 70 58 58 61 74 47 66
Days Payable 102 69 89 52 51 54 52
Cash Conversion Cycle 78 79 84 80 94 66 90
Working Capital Days 100 95 122 83 143 65 71
ROCE % 50% 51% 50% 52% 44% 36%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Exports as % of Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Installed Capacity
MTPA
Number of Products Sold
count
Capacity Utilization
%
Number of Customers Served
count
Pharmaceutical Revenue Share
%
Production Volume
MT
Top 10 Customer Concentration
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

40 Recently
Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21%
1.56% 0.56% 0.49% 0.05% 0.03% 0.03% 0.05% 0.08% 0.04%
4.34% 2.57% 2.20% 2.20% 1.71% 1.93% 2.00% 2.05% 2.07%
19.89% 22.66% 23.10% 23.54% 24.04% 23.84% 23.74% 23.66% 23.68%
No. of Shareholders 32,60439,79238,48937,92237,56935,78034,60833,46932,479

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP